Natalie Osagie, PharmD
M. John Gass, PharmD, BCOP
LENGTH OF RESIDENCY:
Major areas of clinical involvement are supportive care and prevention or management of antineoplastic drug toxicity. Accordingly, oncology/hematology pharmacists are involved in nausea and vomiting prevention, pain management, infection treatment, nutritional support, antineoplastic toxicity of prevention and management, therapeutic drug monitoring, chemotherapy regimen dosing and design, and extravasation management. These services are provided to the medical oncology and hematology/BMTU services at STVHCS in both inpatient and outpatient settings.
Other areas of involvement are coordination and supervision of chemotherapy preparation, patient and staff education, investigational drug control for all southwest Oncology Group (SWOG) protocols and provision of drug information. Oncology Pharmacy Residents are involved in all of these activities to ensure the development of a clinician with comprehensive oncology pharmacy skills. Teaching and clinical research opportunities are also available.
Responsibilities and activities are structured to meet or exceed ASHP standards for oncology pharmacy practice. Residency training is provided under the direction of Megan McKee, PharmD, BCPS, BCOP; Natalie Osagie, PharmD, and John Gass, PharmD, BCOP.The University of Texas at Austin and its affiliated institutions are an Equal Opportunity/Affirmative Action Employer. Qualified women and minorities are encouraged to apply. Security sensitive; conviction verification conducted on applicant selected.
College of Pharmacy
The University of Texas
2409 University Ave.
Austin, TX, USA
Email Address: pharmacy
For specific programs, contact: